Shouguang Fukang Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is OMEPRAZOLE, with a corresponding US DMF Number 22897.
Remarkably, this DMF maintains an Active status since its submission on June 19, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 17, 2014, and payment made on July 02, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II